DCM
ATRC icon

Delpha Capital Management’s AtriCure ATRC Stock Holding History

Delpha Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-586
Closed -$11K – 210
2017
Q4 		$11K Buy
+586
New +$11.6K 0.01% 1021

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HEC
Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Delpha Capital Management's ATRC Position: Q1 2018 in Review

Delpha Capital Management sold out of AtriCure (ATRC) in Q1 2018, closing a stake of 586 shares — an estimated $11K sold.

Delpha Capital Management first reported a position in ATRC in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 108 funds tracked by Wall St. Rank hold ATRC as of Q1 2018.

  • Delpha Capital Management reported no remaining AtriCure position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 586 AtriCure shares in Q1 2018, an estimated $11K.
  • Delpha Capital Management first reported a position in AtriCure in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's AtriCure position peaked at $11K in Q4 2017.
  • 108 funds tracked by Wall St. Rank held AtriCure as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.